Company / Tangible Book Value per Share
Akebia Therapeutics, Inc. Tangible Book Value per Share History
FY2014-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Tangible Book Value per Share
-$0.12
FY2025
5-year range
-$0.56 / $2.29
FY2021-FY2025
Trend
+78.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Tangible Book Value per Share returned to growth in FY2025 after 4 years of decline, reaching $-0.12.
Based on SEC 10-K filings.
-0.12 in FY2025.
Improved from $-0.49 to $-0.12 over the past 2 years.
Tangible Book Value per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, tangible book value per share increased 78.9% year-over-year.
- Peak tangible book value per share was recorded in FY2020.
- Lowest tangible book value per share in the period was in FY2014.
Company context
Key Data Points
- Altman Z-Score -2.76 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Tangible Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$0.12 | +78.9% |
| FY2024 | -$0.56 | -14.3% |
| FY2023 | -$0.49 | -60.1% |
| FY2022 | -$0.30 | -113.3% |
| FY2021 | $2.29 | -51.9% |
| FY2020 | $4.77 | +726.4% |
| FY2019 | $0.58 | +110.5% |
| FY2018 | $0.27 | +104.4% |
| FY2015 | -$6.24 | +85.5% |
| FY2014 | -$43.08 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026